Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ferric Hydroxide-polymaltose
2. Ferric Polymaltose
3. Ferripolyisomaltose
4. Ferrum Hausmann
5. Intrafer
6. Iron Hydroxide Polymaltose
7. Iron Polymaltose
8. Iron(iii)-hydroxide-dextrin
9. Iron-polymaltose Complex
10. Teferrol
1. 79173-09-4
2. (3r,4s,5s,6r)-2-[(2r,3s,4r,5r)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,3s,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;iron;trihydrate
| Molecular Weight | 614.3 g/mol |
|---|---|
| Molecular Formula | C18H38FeO19 |
| Hydrogen Bond Donor Count | 14 |
| Hydrogen Bond Acceptor Count | 19 |
| Rotatable Bond Count | 7 |
| Exact Mass | 614.135665 g/mol |
| Monoisotopic Mass | 614.135665 g/mol |
| Topological Polar Surface Area | 272 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 644 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 13 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 5 |
Hematinics
Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias. (See all compounds classified as Hematinics.)
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Ferric Hydroxide Polymaltose manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ferric Hydroxide Polymaltose, including repackagers and relabelers. The FDA regulates Ferric Hydroxide Polymaltose manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ferric Hydroxide Polymaltose API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ferric Hydroxide Polymaltose supplier is an individual or a company that provides Ferric Hydroxide Polymaltose active pharmaceutical ingredient (API) or Ferric Hydroxide Polymaltose finished formulations upon request. The Ferric Hydroxide Polymaltose suppliers may include Ferric Hydroxide Polymaltose API manufacturers, exporters, distributors and traders.
Ferric Hydroxide Polymaltose Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ferric Hydroxide Polymaltose GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ferric Hydroxide Polymaltose GMP manufacturer or Ferric Hydroxide Polymaltose GMP API supplier for your needs.
A Ferric Hydroxide Polymaltose CoA (Certificate of Analysis) is a formal document that attests to Ferric Hydroxide Polymaltose's compliance with Ferric Hydroxide Polymaltose specifications and serves as a tool for batch-level quality control.
Ferric Hydroxide Polymaltose CoA mostly includes findings from lab analyses of a specific batch. For each Ferric Hydroxide Polymaltose CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ferric Hydroxide Polymaltose may be tested according to a variety of international standards, such as European Pharmacopoeia (Ferric Hydroxide Polymaltose EP), Ferric Hydroxide Polymaltose JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ferric Hydroxide Polymaltose USP).
LOOKING FOR A SUPPLIER?
